Biotechnology Stocks II Performance Guide: Enliven Therapeutics, Inc. (ELVN)
ELVN has no dividends.
Table and Chart of ELVN Performance
See what a $1,000 investment in ELVN is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ELVN Returns | |
|---|---|
| Start Date | Apr-30-2020 |
| Start Price | $70.00 |
| End Date | May-16-2024 |
| End Price | $23.81 |
| # Prices | 50 |
| Min Date | Jul-29-2022 |
| Min Price | $4.68 |
| Max Date | May-29-2020 |
| Max Price | $133.96 |
| Total Return | -65.99% |
| Annualized Return | -22.80% |
| Current Value of $1,000 Purchase | $340 |
| Number Returns | 1,225 |
| Average Return | -4.83% |
| Number Profitable Returns | 366 |
| Percent Profitable Returns | 29.88% |
| Number Unprofitable Returns | 859 |
| Percent Unprofitable Returns | 70.12% |
| Profitable to Unprofitable Returns Ratio | 0.43 |
| ELVN Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,116,181,000 |
| Beta | Price to Sales |
| Earnings per Share | $-1.7500 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 4.004 |
| PRICE DATA | |
| 52 Week High | $26 |
| 52 Week Low | $9.8 |
| Analyst Target Price | $34.33 |
| 50-Day Moving Average | $18.56 |
| 200-Day Moving Average | $15.31 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -26.1% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ELVN Compare Returns with S&P 500
ELVN Trendline Chart
ELVN Moving Average Chart
ELVN Stock Return Map - See Patterns of Gains and Losses
ELVN Stock Returns/Purchase Dates